TNS Advanced+ Serum

SkinMedica

SkinMedica TNS Advanced+ Serum is a dual-chamber product combining two distinct anti-aging technologies. The TNS-MR chamber contains human fibroblast conditioned media — a proprietary blend of growth factors, cytokines, and soluble matrix proteins harvested from neonatal fibroblast cell culture. These signaling molecules aim to recapitulate the growth-factor environment of young skin, stimulating collagen synthesis, elastin production, and cellular renewal. The second chamber contains a peptide-and-botanical blend including Palmitoyl Tripeptide-1, Acetyl Hexapeptide-8 (Argireline), Acetyl Octapeptide-3 (SNAP-8), and additional skin-brightening and antioxidant actives (vitamin C derivatives, Marine Extracts, Albizia Julibrissin bark extract). The two chambers mix upon dispensing. SkinMedica published a 24-week clinical study (n=60) showing improvements in global photodamage score, fine lines, and skin texture with TNS Advanced+ Serum vs. vehicle control. The growth-factor approach is controversial — critics note that topically applied growth factors face penetration barriers and the specific cytokine profile of conditioned media varies between production lots. Supporters point to the clinical data and the biological plausibility that even partial penetration delivers meaningful signaling. Distributed primarily through dermatologist offices and medical spas. SkinMedica is an Allergan (AbbVie) brand, often bundled with Botox and Juvederm treatment protocols.

Links to retailers are affiliate links. We may earn a commission on qualifying purchases at no extra cost to you.